Larry Don Bratton

Title: The Innovations of Larry Don Bratton

Introduction

Larry Don Bratton is a notable inventor based in Westminster, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as histamine receptor antagonists and tachykinin receptor antagonists. His work has implications for treating various medical conditions, including allergic rhinitis and inflammatory bowel diseases.

Latest Patents

Larry Don Bratton holds a patent for a novel compound described as substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl)benzamide derivatives. This invention is particularly useful in the treatment of conditions such as asthma, bronchitis, and emesis. The patent highlights the potential of these compounds to improve patient outcomes in various allergic and inflammatory conditions.

Career Highlights

Bratton has had a distinguished career, working with Hoechst Marion Roussel, a company known for its innovative pharmaceutical products. His expertise in medicinal chemistry has allowed him to contribute to the development of important therapeutic agents.

Collaborations

Throughout his career, Larry has collaborated with notable colleagues, including George D. Maynard and John M. Kane. These collaborations have fostered an environment of innovation and have led to advancements in pharmaceutical research.

Conclusion

Larry Don Bratton's contributions to the field of pharmaceuticals through his innovative patents and collaborations have made a significant impact on medical treatments. His work continues to influence the development of new therapies for various health conditions.